logo

MNMD

Mind MedicineยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MNMD Profile

Mind Medicine (Mindmed) Inc.

A clinical stage biopharmaceutical company developing novel products to treat brain health disorders

Pharmaceutical
--
04/27/2021
NASDAQ Stock Exchange
74
12-31
Common stock
One World Trade Center, Suite 8500, New York, New York 10007
--
Mind Medicine (MindMed) Inc., incorporated in Canada. They are a clinical-stage neurodrug development company that develops psychedelic-based drug candidates through rigorous scientific and clinical trials. Their mission is to discover, develop and deploy psychedelic-inspired drugs and therapies to treat psychiatry, neurology, addiction, pain, and potentially other disorders such as anxiety, substance abuse and withdrawal, and adult attention deficit disorder.